AKT1 and breast carcinoma: Zhu et al. (2021) found that the migration and invasion of breast cancer cells was inhibited by α-MG due to the cleavage of poly ADP-ribose polymerase (PARP) and apoptosis via the PI3K/protein kinase B (AKT) signaling pathway targeting RXR α.